Drug Shortage Report for BIPHENTIN
| Report ID | 168970 |
| Drug Identification Number | 02277182 |
| Brand name | BIPHENTIN |
| Common or Proper name | methylphenidate hydrochloride Controlled Release Capsules |
| Company Name | ELVIUM LIFE SCIENCES |
| Market Status | MARKETED |
| Active Ingredient(s) | METHYLPHENIDATE HYDROCHLORIDE |
| Strength(s) | 40MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | N06BA |
| ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2022-09-08 |
| Actual start date | 2022-09-08 |
| Estimated end date | 2022-11-14 |
| Actual end date | 2022-11-14 |
| Shortage status | Resolved |
| Updated date | 2022-11-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.